Clinical Trial Update: Effect of Refnot on Immunity in Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Refnot on immunity in cancer patients with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Refnot

Snippet

Sponsor: Refnot-Pharm Ltd | Conditions: Solid Tumor | Phase 2 | Status: COMPLETED